tirzepatide news november 2025 Trump drug price deal: Burning questions after Lilly, Novo agreement November 2025 Drug Safety: Recalls

In the LEADER trial, over 9,340 patients with type 2 diabetes and high cardiovascular disease risk underwent randomization to liraglutide or placebo and were followed for a median of 3.8 years resulting in a 13% risk reduction in a combined endpoint of death from cardiovascular cause, nonfatal myocardial infarction, or nonfatal stroke [46]

Maintaining your weight loss requires a deliberate strategy that combines behavioral modification, continued medical support, and understanding your individual metabolic profile

The medical approach helped me lose weight in a way that feels manageable and realistic

The standard Zepbound titration ladder climbs in 2.5 mg steps every four weeks

GLP-1 Semaglutide manages blood sugar levels by regulating insulin and glucagon, important for Type 2 diabetes and weight control